Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat

Abstract

Bovine leukemia virus (BLV) is a B-lymphotropic oncogenic retrovirus whose transcriptional promoter is located in the viral 5′ long terminal repeat (LTR). To date, no B-lymphocyte-specific cis-regulatory element has been identified in this region. Since ETS proteins are known to regulate transcription of numerous retroviruses, we searched for the presence in the BLV promoter region of binding sites for PU.1/Spi-1, a B-cell- and macrophage-specific ETS family member. In this report, nucleotide sequence analysis of the viral LTR identified a PUbox located at −95/−84 bp. We demonstrated by gel shift and supershift assays that PU.1 and the related Ets transcription factor Spi-B interacted specifically with this PUbox. A 2-bp mutation (GGAA→CCAA) within this motif abrogated PU.1/Spi-B binding. This mutation caused a marked decrease in LTR-driven basal gene expression in transient transfection assays of B-lymphoid cell lines, but did not impair the responsiveness of the BLV promoter to the virus-encoded transactivator TaxBLV. Moreover, ectopically expressed PU.1 and Spi-B proteins transactivated the BLV promoter in a PUbox-dependent manner. Taken together, our results provide the first demonstration of regulation of the BLV promoter by two B-cell-specific Ets transcription factors, PU.1 and Spi-B. The PU.1/Spi-B binding site identified here could play an important role in BLV replication and B-lymphoid tropism.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Adam E, Kerkhofs P, Mammerickx M, Burny A, Kettman R and Willems L . (1996). J. Virol., 70, 1990–1999.

  • Adam E, Kerkhofs P, Mammerickx M, Kettmann R, Burny A, Droogmans L and Willems L . (1994). J. Virol., 68, 5845–5853.

  • Aida Y, Miyasaka M, Okada K, Onuma M, Kogure S, Suzuki M, Minoprio P, Levy D and Ikawa Y . (1989). Am. J. Vet. Res., 50, 1946–1951.

  • Aurrekoetxea-Hernandez K and Buetti E . (2000). J. Virol., 74, 4988–4998.

  • Bloom JC, Ganjam VK and Gabuzda TG . (1980). Cancer Res., 40, 2240–2244.

  • Bloom JC, Kenyon SJ and Gabuzda TG . (1979). Blood, 53, 899–912.

  • Bosselut R, Duvall JF, Gegonne A, Bailly M, Hemar A, Brady J and Ghysdael J . (1990). EMBO J., 9, 3137–3144.

  • Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K and Siebenlist U . (1993). Cell, 72, 729–739.

  • Bradford MM . (1976). Anal. Biochem., 72, 248–254.

  • Brooks PA, Cockerell GL and Nyborg JK . (1998). Virology, 243, 94–98.

  • Brooks PA, Nyborg JK and Cockerell GL . (1995). J. Virol., 69, 6005–6009.

  • Burny A, Bruck C, Chantrenne H, Cleuter Y, Dekegel D, Ghysdael J, Kettman R, Leclercq M, Leunen J, Mammerickx M and Portetelle D . (1987a). Viral Oncology. Klein G (ed). Raven Press: New York, pp. 231–289.

    Google Scholar 

  • Burny A, Cleuter Y, Kettmann R, Mammerickx M, Marbaix G, Portetelle D, Van den BA, Willems L and Thomas R . (1987b). Cancer Surv., 6, 139–159.

  • Burny A, Willems L, Callebaut I, Adam E, Cludts I, Dequiedt F, Droogmans L, Grimonpont C, Kerkhofs P, Mammerickx M, Portetelle D, Van den Broeke A and Kettman R . (1994). Viruses and Cancer. Minson AC, Neil JC, McRae MA (eds). Cambridge University Press: Cambridge, UK, pp. 213–234.

    Google Scholar 

  • Calomme C, Nguyen TL, de Launoit Y, Kiermer V, Droogmans L, Burny A and Van Lint C . (2002). J. Biol. Chem., 277, 8775–8789.

  • Carey JO, Posekany KJ, deVente JE, Pettit GR and Ways DK . (1996). Blood, 87, 4316–4324.

  • Carvalho M and Derse D . (1993). J. Virol., 67, 3885–3890.

  • Carvalho M, Kirkland M and Derse D . (1993). J. Virol., 67, 6586–6595.

  • Chen H, Ray-Gallet D, Zhang P, Hetherington CJ, Gonzalez DA, Zhang DE, Moreau-Gachelin F and Tenen DG . (1995a). Oncogene, 11, 1549–1560.

  • Chen HM, Pahl HL, Scheibe RJ, Zhang DE and Tenen DG . (1993). J. Biol. Chem., 268, 8230–8239.

  • Chen HM, Zhang P, Voso MT, Hohaus S, Gonzalez DA, Glass CK, Zhang DE and Tenen DG . (1995b) Blood, 85, 2918–2928.

  • Clark NM, Smith MJ, Hilfinger JM and Markovitz DM . (1993). J. Virol., 67, 5522–5528.

  • Dahl R, Ramirez-Bergeron DL, Rao S and Simon MC . (2002). EMBO J., 21, 2220–2230.

  • Dash PK, Karl KA, Colicos MA, Prywes R and Kandel ER . (1991). Proc. Natl. Acad. Sci. USA, 88, 5061–5065.

  • Derse D . (1987). J. Virol., 61, 2462–2471.

  • Derse D and Casey JW . (1986). Science, 231, 1437–1440.

  • Djilali S, Parodi AL, Levy D and Cockerell GL . (1987) Leukemia, 1, 777–781.

  • Eisenbeis CF, Singh H and Storb U . (1993). Mol. Cell Biol., 13, 6452–6461.

  • Eisenbeis CF, Singh H and Storb U . (1995). Genes Dev., 9, 1377–1387.

  • Erselius JR, Jostes B, Hatzopoulos AK, Mosthaf L and Gruss P . (1990). J. Virol., 64, 1657–1666.

  • Feinman R, Qiu WQ, Pearse RN, Nikolajczyk BS, Sen R, Sheffery M and Ravetch JV . (1994). EMBO J., 13, 3852–3860.

  • Ferrer JF . (1979). J. Am. Vet. Med. Assoc., 175, 1281–1286.

  • Ford AM, Bennett CA, Healy LE, Towatari M, Greaves MF and Enver T . (1996). Proc. Natl. Acad. Sci. USA, 93, 10838–10843.

  • Galson DL, Hensold JO, Bishop TR, Schalling M, D'Andrea AD, Jones C, Auron PE and Housman DE . (1993). Mol. Cell Biol., 13, 2929–2941.

  • Gitlin SD, Bosselut R, Gegonne A, Ghysdael J and Brady JN . (1991). J. Virol., 65, 5513–5523.

  • Gitlin SD, Dittmer J, Shin RC and Brady JN . (1993). J. Virol., 67, 7307–7316.

  • Goebl MK . (1990). Cell, 61, 1165–1166.

  • Henkel G and Brown MA . (1994). Proc. Natl. Acad. Sci. USA, 91, 7737–7741.

  • Heydemann A, Juang G, Hennessy K, Parmacek MS and Simon MC . (1996). Mol. Cell Biol., 16, 1676–1686.

  • Himmelmann A, Thevenin C, Harrison K and Kehrl JH . (1996). Blood, 87, 1036–1044.

  • Holzmeister J, Ludewig B, Pauli G and Simon D . (1993). Biochem. Biophys. Res. Commun., 197, 1229–1233.

  • Horvai A, Palinski W, Wu H, Moulton KS, Kalla K and Glass CK . (1995). Proc. Natl. Acad. Sci. USA, 92, 5391–5395.

  • Hromas R, Orazi A, Neiman RS, Maki R, Van Beveran C, Moore J and Klemsz M . (1993). Blood, 82, 2998–3004.

  • Hu CJ, Rao S, Ramirez-Bergeron DL, Garrett-Sinha LA, Gerondakis S, Clark MR and Simon MC . (2001). Immunity, 15, 545–555.

  • Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K and Berkhout B . (2000). J. Virol., 74, 3740–3751.

  • Jensen WA, Wicks-Beard BJ and Cockerell GL . (1992). J. Virol,. 66, 4427–4433.

  • Karim FD, Urness LD, Thummel CS, Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA, Gunther CV and Nye JA . (1990). Genes Dev., 4, 1451–1453.

  • Katoh I, Yoshinaka Y and Ikawa Y . (1989). EMBO J., 8, 497–503.

  • Kettman R, Burny A, Callebaut I, Droogmans L, Mammerickx M, Willems L and Portetelle D . (1994). The Retroviridae, vol. 3. Levy JA (ed). Plenum Press: New York, NY, pp. 39–81.

    Book  Google Scholar 

  • Kiermer V, Van Lint C, Briclet D, Vanhulle C, Kettmann R, Verdin E, Burny A and Droogmans L . (1998). J. Virol., 72, 5526–5534.

  • Kiernan RE, Vanhulle C, Schiltz L, Adam E, Xiao H, Maudoux F, Calomme C, Burny A, Nakatani Y, Jeang KT, Benkirane M and Van Lint C . (1999). EMBO J., 18, 6106–6118.

  • Kihara-Negishi F, Yamamoto H, Suzuki M, Yamada T, Sakurai T, Tamura T and Oikawa T . (2001). Oncogene, 20, 6039–6047.

  • Klemsz MJ, McKercher SR, Celada A, Van Beveren C and Maki RA . (1990). Cell, 61, 113–124.

  • Kodandapani R, Pio F, Ni CZ, Piccialli G, Klemsz M, McKercher S, Maki RA and Ely KR . (1996). Nature, 380, 456–460.

  • Kominato Y, Galson D, Waterman WR, Webb AC and Auron PE . (1995). Mol. Cell Biol., 15, 59–68.

  • Lagarias DM and Radke K . (1989). J. Virol., 63, 2099–2107.

  • Laux G, Adam B, Strobl LJ and Moreau-Gachelin F . (1994). EMBO J., 13, 5624–5632.

  • Leiden JM, Wang CY, Petryniak B, Markovitz DM, Nabel GJ and Thompson CB . (1992). J. Virol., 66, 5890–5897.

  • Li SL, Schlegel W, Valente AJ and Clark RA . (1999). J. Biol. Chem., 274, 32453–32460.

  • Lodie TA, Reiner M, Coniglio S, Viglianti G and Fenton MJ . (1998). J. Immunol., 161, 268–276.

  • Lodie TA, Savedra Jr R, Golenbock DT, Van Beveren CP, Maki RA and Fenton MJ . (1997). J. Immunol., 158, 1848–1856.

  • Lopez-Rovira T, Chalaux E, Rosa JL, Bartrons R and Ventura F . (2000). J. Biol. Chem., 275, 28937–28946.

  • Maitra S and Atchison M . (2000). Mol. Cell Biol., 20, 1911–1922.

  • Mao C, Ray-Gallet D, Tavitian A and Moreau-Gachelin F . (1996). Oncogene, 12, 863–873.

  • Marecki S and Fenton MJ . (2000). Cell Biochem. Biophys., 33, 127–148.

  • Markovitz DM, Smith MJ, Hilfinger J, Hannibal MC, Petryniak B and Nabel GJ . (1992). J. Virol., 66, 5479–5484.

  • Moreau-Gachelin F . (1994). Biochim. Biophys. Acta, 1198, 149–163.

  • Moreau-Gachelin F, Ray D, Mattei MG, Tambourin P and Tavitian A . (1989). Oncogene, 4, 1449–1456.

  • Moreau-Gachelin F, Tavitian A and Tambourin P . (1988). Nature, 331, 277–280.

  • Muller S, Sideras P, Smith CI and Xanthopoulos KG . (1996). Oncogene, 13, 1955–1964.

  • Myers G, Korber B, Hahn BH, Jeang K-T, Mellors JH, Mc-Cutchan FE, Henderson LE and Pavlakis GN . (1995). Human Retroviruses and AIDS. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory: Los Alamos, New Mexico. Published by Theoretical Biology and Biophysiccs.

    Google Scholar 

  • Nelsen B, Tian G, Erman B, Gregoire J, Maki R, Graves B and Sen R . (1993). Science, 261, 82–86.

  • Niermann GL and Buehring GC . (1997). Virology, 239, 249–258.

  • Nikolajczyk BS, Sanchez JA and Sen R . (1999). Immunity, 11, 11–20.

  • Nuchprayoon I, Simkevich CP, Luo M, Friedman AD and Rosmarin AG . (1997). Blood, 89, 4546–4554.

  • Oelgeschlager M, Nuchprayoon I, Luscher B and Friedman AD . (1996). Mol. Cell. Biol., 16, 4717–4725.

  • Osborn L, Kunkel S and Nabel GJ . (1989). Proc. Natl. Acad. Sci. USA, 86, 2336–2340.

  • Pahl HL, Scheibe RJ, Zhang DE, Chen HM, Galson DL, Maki RA and Tenen DG . (1993). J. Biol. Chem., 268, 5014–5020.

  • Paul R, Schuetze S, Kozak SL, Kozak CA and Kabat D . (1991). J. Virol., 65, 464–467.

  • Perez C, Coeffier E, Moreau-Gachelin F, Wietzerbin J and Benech PD . (1994) Mol. Cell. Biol., 14, 5023–5031.

  • Pio F, Kodandapani R, Ni CZ, Shepard W, Klemsz M, McKercher SR, Maki RA and Ely KR . (1996). J. Biol. Chem., 271, 23329–23337.

  • Pongubala JM, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA and Atchison ML . (1992). Mol. Cell. Biol., 12, 368–378.

  • Pongubala JM, Van Beveren C, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA and Atchison ML . (1993). Science, 259, 1622–1625.

  • Posada R, Pettoello-Mantovani M, Sieweke M, Graf T and Goldstein H . (2000). AIDS Res. Hum. Retroviruses, 16, 1981–1989.

  • Quang CT, Pironin M, von Lindern M, Beug H and Ghysdael J . (1995). Oncogene, 11, 1229–1239.

  • Rao S, Garrett-Sinha LA, Yoon J and Simon MC . (1999a). J. Biol. Chem., 274, 34245–34252.

  • Rao S, Matsumura A, Yoon J and Simon MC . (1999b). J. Biol. Chem., 274, 11115–11124.

  • Ray-Gallet D, Mao C, Tavitian A and Moreau-Gachelin F . (1995). Oncogene, 11, 303–313.

  • Ray D, Bosselut R, Ghysdael J, Mattei MG, Tavitian A and, Moreau-Gachelin F . (1992). Mol. Cell Biol., 12, 4297–4304.

  • Rosen CA, Sodroski JG, Kettman R, Burny A and Haseltine WA . (1985). Science, 227, 320–322.

  • Rosen CA, Sodroski JG, Kettman R and Haseltine WA . (1986). J. Virol., 57, 738–744.

  • Rosmarin AG, Caprio D, Levy R and Simkevich C . (1995a). Proc. Natl. Acad. Sci. USA, 92, 801–805.

  • Rosmarin AG, Caprio DG, Kirsch DG, Handa H and, Simkevich CP . (1995b). J. Biol. Chem., 270, 23627–23633.

  • Sagata N, Yasunaga T, Tsuzuku-Kawamura J, Ohishi K, Ogawa Y and Ikawa Y . (1985). Proc. Natl. Acad. Sci. USA, 82, 677–681.

  • Scott EW, Simon MC, Anastasi J and Singh H . (1994). Science, 265, 1573–1577.

  • Seeler JS, Muchardt C, Podar M and Gaynor RB . (1993). Virology, 196, 442–450.

  • Shin MK and Koshland ME . (1993). Genes Dev., 7, 2006–2015.

  • Smith LT, Hohaus S, Gonzalez DA, Dziennis SE and Tenen DG . (1996). Blood, 88, 1234–1247.

  • Smith Jr MF, Carl VS, Lodie T and Fenton MJ . (1998). J. Biol. Chem., 273, 24272–24279.

  • Su GH, Ip HS, Cobb BS, Lu MM, Chen HM and Simon MC . (1996). J. Exp. Med., 184, 203–214.

  • Tanimura A, Teshima H, Fujisawa J and Yoshida M . (1993). J. Virol., 67, 5375–5382.

  • Tsukada J, Misago M, Serino Y, Ogawa R, Murakami S, Nakanishi M, Tonai S, Kominato Y, Morimoto I, Auron PE and Eto S . (1997). Blood, 90, 3142–3153.

  • Van Lint C, Ghysdael J, Paras Jr P, Burny A and Verdin E . (1994). J. Virol., 68, 2632–2648.

  • Verhoef K, Sanders RW, Fontaine V, Kitajima S and Berkhout B . (1999). J. Virol., 73, 1331–1340.

  • Wasylyk B, Hahn SL and Giovane A . (1993). Eur. J. Biochem., 211, 7–18.

  • Willems L, Burny A, Collete D, Dangoisse O, Dequiedt F, Gatot JS, Kerkhof P, Lefebvre L, Merezak C, Peremans T, Portetelle D, Twizere JC and Kettmann R . (2000). AIDS Res. Hum. Retroviruses, 16, 1787–1795.

  • Willems L, Burny A, Dangoisse O, Collete D, Dequiedt F, Gatot JS, Kerkhofs P, Lefèbvre L, Merezak C, Portetelle D, Twizere JC and Kettmann R . (1999). Curr. Top. Virol., 1, 139–167.

  • Willems L, Thienpont E, Kerkhofs P, Burny A, Mammerickx M and Kettmann R . (1993). J. Virol., 67, 1086–1089.

  • Xiao J and Buehring GC . (1998). J. Virol., 72, 5994–6003.

  • Yamamoto H, Kihara-Negishi F, Yamada T, Hashimoto Y and Oikawa T . (1999). Oncogene, 18, 1495–1501.

  • Yamamoto H, Kihara-Negishi F, Yamada T, Suzuki M, Nakano T and Oikawa T . (2002). Cell. Growth Differ., 13, 69–75.

  • Yang Z, Wara-Aswapati N, Chen C, Tsukada J and Auron PE . (2000). J. Biol. Chem., 275, 21272–21277.

  • Zhang DE, Hetherington CJ, Chen HM and Tenen DG . (1994). Mol. Cell. Biol., 14, 373–381.

Download references

Acknowledgements

We thank Drs Luc Willems and Richard Kettmann (Faculty of Agronomy, Gembloux, Belgium) for the gift of the eukaryotic expression vector pSG-TAXBLV, Dr Shigetaka Kitajima (Medical Research Institute, Tokyo, Japan) for the gift of the anti-GABP antibody, Dr Vincent Bours (Center for Molecular and Cellular Therapy, Université de Liège, Belgium) for the gift of the GST-p50 and GST-p65 vectors, Dr Meinrad Busslinger (Research Institute of Molecular Pathology, Vienna, Austria) for the gift of the anti-Pax5 antibody, and Drs Françoise Moreau-Gachelin (Institut Curie, Paris, France) and Simon Celeste (Howard Hughes Medical Institute, Philadelphia, Pennsylvania) for the gift of Spi-B reagents. This work was supported by grants to CVL from the ‘Fonds National de la Recherche Scientifique’ (FNRS, Belgium), the FNRS-Télévie Program, the Free University of Brussels (ARC program 98/03-224), the Internationale Brachet Stiftung (IBS), the CGRI-INSERM cooperation, the Region Wallonne-Commission Européenne FEDER and the Theyskens-Mineur Foundation. CVL and AD are ‘Maître de Recherches’ and ‘Aspirant’ of the FNRS, respectively. CC and SN are fellows of the FNRS-Télévie Program.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carine Van Lint.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dekoninck, A., Calomme, C., Nizet, S. et al. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat. Oncogene 22, 2882–2896 (2003). https://doi.org/10.1038/sj.onc.1206392

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206392

Keywords

This article is cited by

Search

Quick links